TRANSLATIONAL RELEVANCE
associated with the disease. Some of these miRNAs were likely to play a role in disease 10 progression given their observed correlation with clinical course. Finally, these miRNAs were 11 different from those found to be deregulated in CLLs with known chromosomal abnormalities.
INTRODUCTION 1 2
Chronic lymphocytic leukemia (CLL) is a disease of mature B-cells and represents the most 3 common leukemia in Western countries (1). Despite the rather homogeneous immunophenotype 4 (CD19+, CD20+, CD5+, and CD23+), CLL is clinically heterogeneous. Some patients progress very 5 slowly towards more advanced stages and may never require therapy or only after years from 6 diagnosis, while others require an early treatment. Despite the recent therapeutic advances, 7 progressive CLL cases almost always become incurable diseases. The clinical outcome of CLL can 8 be predicted based upon cellular and molecular markers, including the presence or absence of 9 somatic mutations at the IGHV locus, or ZAP-70 and CD38 expression in neoplastic cells (1). 10 Cytogenetic aberrations, including 17p and 11q deletions as well as trisomy 12, have also been 11 related to poor prognosis (2). More recently, mutations in TP53, NOTCH1, SF3B1, and BIRC3 genes 12 were shown to predict poor outcome (3). In addition, expression of certain microRNAs (miRNAs) 13 by leukemic cells can provide useful information of prognostic relevance (4). Figure 3) ; only miR-181b, which showed a significant down-regulation in 23 microarray studies, did not achieve a significant difference in PCR analyses, likely because of the 24 wide distribution of expression levels among samples.
MATERIALS AND METHODS

26
MiRNA expression in CLL subgroups stratified according to IGHV gene somatic mutations 27 We next compared miRNA expression of M-CLL (n = 131) versus UM-CLLs (n = 82) The analysis 28 identified 14 differentially expressed miRNAs based on selection criteria of an average log2 29 expression > 0.0 in at least one of the classes, fold change > 1.5, and Welch t-test p < 0.05 (Table   30 2). Because the results based on all CLL samples could have been influenced by heterogeneity of Some of the other miRNAs discriminating UM-CLL versus M-CLL, namely miR-146b-5p, miR-29c, 1 miR-625 and miR-532-3p, were further analyzed with RT-qPCR providing good and significant 2 correlation coefficients with microarray analysis (Supplementary Figure 5) . 3 4 MiRNA expression by CLL cells with defined cytogenetic aberrations 5 To identify characteristic patterns of miRNA expression associated with each of the major 6 cytogenetic aberrations, we compared miRNA expression in the different cytogenetic CLL 7 subgroups. FISH "negative" CLLs were considered as a single subgroup; when 13q-was present 8 together with another cytogenetic abnormality, we considered the latter as predominant in 9 determining group inclusion. By selecting the top miRNAs differentially expressed in each 10 cytogenetic subgroup versus all other CLLs and applying a Kruskal-Wallis test to confirm that they 11 were the best performing miRNAs, we generated a short list of miRNAs that could be specifically 12 associated with each FISH group ( Table 3 Table 1 , the low expression of five 28 miRNAs (miR-26a, miR-532-3p, miR-532-5p, miR-502-3p and miR-660) was significantly associated 29 with a shorter PFS (Figure 3) . Among the 14 miRNAs in Table 2 , nine showed significant association 30 with PFS (Figure 3) . In particular, CLL cases with miR-29c*, miR-532-3p, miR-146b-5p, miR-139-3p, CLL cells, as it has also been described for miRNA-29b in a form of indolent mouse lymphoma (50), 10 and promotes an aggressive form of CLL when down-regulated. 11 Finally, some of the miRNAs associated with cytogenetic abnormalities or IGHV mutational 12 status were also associated with PFS by univariate analyses. The high expression of miR-29c*, miR-13 532-3p, miR-146b-5p, miR-139-3p, miR-222 and miR-29c was associated with a reduced risk of 14 disease progression, while the opposite was true for miR-338-3p, miR-574-3p and miR-16. 15 Likewise, among the miRNAs associated with cytogenetic abnormalities, high levels of miR-146b-16 5p appeared to have a protective effect from disease progression while the opposite was observed 17 for miR-155, miR-338-3p and miR-16. Some of these miRNA (miR-29c, miR-146, miRNA-222 and 18 miR-155) were included in an earlier miRNA-based signature associated with PFS prediction (4). 19 However, among all the above, only miR-26a and miR-532-3p (found to be significant in the 
